The hypotension and the release of atrial natriuretic peptide induced by the myocardial infarction are thought to be the main mechanisms that mediate the inhibition of gut motility, possibly via the non-adrenergic and non-cholinergic pathways [37,38]. The gene discussed is NPPA; the disease is myocardial infarction.